Bluejay Therapeutics Announces $182 Million Series C
SAN MATEO — Bluejay Therapeutics, a leader in the development of novel therapeutics, announced the…
SAN MATEO — Bluejay Therapeutics, a leader in the development of novel therapeutics, announced the…
FREMONT -- Attovia Therapeutics has closed a $105 million oversubscribed Series B financing, bringing the…
NVIDIA founder and CEO Jensen Huang will deliver a keynote address ahead of COMPUTEX 2024, in Taipei,…